問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
China Medical University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-11-01 - 2022-08-29
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting6Sites
2022-01-03 - 2023-12-31
Participate Sites4Sites
Recruiting4Sites
2021-10-20 - 2025-04-30
Participate Sites3Sites
Recruiting3Sites
2021-07-21 - 2023-03-29
Participate Sites8Sites
Recruiting8Sites
2022-03-01 - 2027-08-31
Participate Sites12Sites
Recruiting12Sites
2021-12-01 - 2025-01-25
Gastric Cancer,Gastroesophageal Junction Adenocarcinoma
Bemarituzumab (AMG 552, FPA144)
2023-04-13 - 2027-05-05
Participate Sites13Sites
Recruiting13Sites
2023-03-01 - 2027-02-28
Participate Sites17Sites
Recruiting17Sites
2023-05-01 - 2027-06-24
Ischemic Stroke; Ischemic Attack, Transient
Milvexian
2023-01-01 - 2025-06-30
全部
